# Resveratrol for Exudative Age-Related Macular Degeneration

> **NCT02625376** · NA · TERMINATED · sponsor: **Poitiers University Hospital** · enrollment: 25 (actual)

## Conditions studied

- AMD
- Age-related Macular Degeneration
- Choroidal Neovascularisation

## Interventions

- **DIETARY_SUPPLEMENT:** Resvega
- **DIETARY_SUPPLEMENT:** Trans-Resveratrol
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT02625376
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08-06
- **Primary completion:** 2016-10-26
- **Final completion:** 2016-11-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02625376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02625376, "Resveratrol for Exudative Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02625376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*